@hadeanventures - Hadean Ventures

Gesynta Pharma’s drug candidate GS-248 granted Orphan Drug Designation by the FDA

Gesynta Pharma’s drug candidate GS-248 granted Orphan Drug Designation in US by the FDA for…

Alex Therapeutics aspires to become the global go-to partner for pharma, and other life-science companies…

Alex Therapeutics is a digital therapeutics (DTx) company based in Stockholm...

TargED Biopharmaceuticals (“TargED”), is a private biotechnology company...

TargED Biopharmaceuticals raises EUR 39 Million in Series A financing

Ribbon Biolabs are developing a new technology to synthesize DNA molecules...

Ribbon Biolabs Raises EUR 18 Million Series A Financing

Emergence Therapeutics is a European biopharmaceutical company...

Series A round led by Pontifax and includes new and existing investors Lead product is…

Hadean Ventures Announces the 1st Closing of EUR 90m for its Second Fund...